EPISURF MEDICAL AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.377 SEK | -2.71% |
|
-6.91% | -61.92% |
| Apr. 24 | Episurf Medical Announces Distributor Agreement with Depuy-Synthes | CI |
| Apr. 24 | Episurf Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 17.12M 1.6M | Sales 2025 * | 36.71M 3.44M | Capitalization | 104M 9.7M |
|---|---|---|---|---|---|
| Net income 2024 * | -69M -6.46M | Net income 2025 * | -57M -5.33M | EV / Sales 2024 * | 5.82 x |
| Net cash position 2024 * | 4M 374K | Net Debt 2025 * | 9M 842K | EV / Sales 2025 * | 3.07 x |
| P/E ratio 2024 * |
-1.72
x | P/E ratio 2025 * |
-1.95
x | Employees | 25 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.85% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -2.71% | ||
| 1 week | -6.91% | ||
| Current month | +4.00% | ||
| 1 month | -5.75% | ||
| 3 months | -58.62% | ||
| 6 months | -63.75% | ||
| Current year | -61.92% |
1 week
0.38
0.42
1 month
0.320.49
Current year
0.321.23
1 year
0.321.43
3 years
0.325.91
5 years
0.325.91
10 years
0.3265.50
| Managers | Title | Age | Since |
|---|---|---|---|
Pål Ryfors
CEO | Chief Executive Officer | 41 | 15-12-13 |
Patrick Jamnik
PSD | President | 41 | 20-12-31 |
Veronica Wallin
DFI | Director of Finance/CFO | 38 | 16-07-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Laura Shunk
BRD | Director/Board Member | 67 | 17-05-21 |
Ulf Grunander
CHM | Chairman | 70 | 21-04-30 |
| Director/Board Member | 62 | 20-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-21 | 0.377 | -2.71% | 123 923 |
| 24-05-20 | 0.3875 | -2.76% | 199,872 |
| 24-05-17 | 0.3985 | +0.13% | 149,373 |
| 24-05-16 | 0.398 | +2.98% | 497,721 |
| 24-05-15 | 0.3865 | -4.57% | 277,789 |
Delayed Quote Nasdaq Stockholm, May 21, 2024 at 09:57 am EDT
More quotes
Episurf Medical AB is a Sweden-based medical technology company. It is engaged in the development, manufacture and marketing of implants and surgical drilling templates used in the treatment of local cartilage damage in knee joints. The Companyâs product portfolio includes the Episealer, and individually customized implant used as a cartilage replacement for early-stage patients; and Epiguide, a drill guide designed to attach to the kneeâs surface, as well as related surgical tools. The personalization of implants and instruments is based on magnetic resonance imaging (MRI) and enables less invasive treatment. The process of ordering and creation of patient-specific implants and surgical instruments is covered by software suite, microiFidelity, comprising microiClinic, microiDesign and microiManufacture. The main shareholder of the Company is Serendipity Ixora Fund AB.
Calendar
2024-05-22
- Extraordinary Shareholders Meeting
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -61.92% | 9.69M | |
| +10.17% | 126B | |
| -5.66% | 11.33B | |
| +6.07% | 9.27B | |
| +36.44% | 5.5B | |
| -21.73% | 4.61B | |
| +8.68% | 3.45B | |
| -8.76% | 2.81B | |
| -10.91% | 2.09B | |
| -6.38% | 2.08B |
- Stock Market
- Equities
- EPIS B Stock
